A study published in JAMA Network Open examined pharmacy barriers faced by patients prescribed buprenorphine to treat opioid use disorder (OUD) through telemedicine. The findings show that pharmacy-related challenges were common, with nearly one-third of study participants (31.9%) reporting going without buprenorphine at some point in the prior 12 months due to pharmacy-related barriers. Researchers surveyed 601 adults who were receiving treatment from a multistate telemedi

A randomized clinical trial published in JAMA Network Open found that incorporating online group mindfulness sessions into buprenorphine treatment for opioid use disorder (OUD) significantly reduced opioid cravings compared to treatment as usual. The study, led by Dr. Zev Schuman-Olivier and colleagues from Cambridge Health Alliance and Harvard Medical School, examined the effectiveness of a 24-week virtual mindfulness-based program compared to a standard recovery support gr

A new report from the Substance Abuse and Mental Health Services Administration (SAMHSA) on Treatment Episode Data Set (TEDS) provides a detailed snapshot of substance use disorder treatment services across the United States. Findings are drawn from nearly 1.5 million treatment admissions and 1.4 million discharges reported in 2022 and show that 35.5% of admissions were for alcohol use, 16.9% were for heroin use, 13.9% were for methamphetamine use, 11.7% were for other opia

The Substance Use and Mental Health Services Administration (SAMHSA) announced updated guidelines that expand the incentive cap for...

CDC data shows a 10% drop in overdose deaths this year.

As the opioid crisis continues to devastate communities across the United States, claiming thousands of lives each year, the HEALing...

Effective treatments for substance use disorder (SUD) can substantially improve patient outcomes. First-line medications like...

Data dashboards are powerful tools that can support community engagement and decision-making by providing public health surveillance and...

In the United States, at least one infant is born with Neonatal Opioid Withdrawal Syndrome (NOWS) every 24 minutes. Opioid-exposed...